2m 2m 2m 2m 2m 2m 2m
Madrigal Pharmct (MDGL)
NASDAQ
$513.64+$0.75 (+0.15%)
Price as of Jun 23, 2026 4:10 PM EDT- $11.8BMarket Cap
- 81.24%1-Year Change
- BiotechnologyIndustry
Madrigal Pharmct (MDGL)
$513.64+$0.75 (+0.15%)
MDGL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $512.88 | ||
Change | +$7.13 (+1.41%) | ||
Open | $513.23 | ||
High | $517.54 | ||
Low | $500.80 | ||
Previous Close | $505.75 | ||
Volume | 281,844 | ||
30-Day Average Volume | 286,779 | ||
1-Week Change | 2.63% | ||
1-Month Change | -0.85% | ||
1-Year Change | 81.24% | ||
3-Year Change | 110.71% | ||
5-Year Change | 401.74% | ||
Fundamentals | |||
Shares Outstanding | 23.1M | ||
Total Assets | $1.2B | ||
Market Cap | $11.8B | ||
Enterprise Value | $11.9B | ||
Period: QTR TTM FY | |||
Revenue | $311.3M | ||
Net Income | -$94.4M | ||
Free Cash Flow | -$171.3M | ||
EBIT | -$94.4M | ||
EBITDA | -$94.0M | ||
Net Working Capital | $844.0M | ||
EPS | -$3.25 | ||
Enterprise Value/EBITDA | -127 | ||
Enterprise Value/Revenue | 38 | ||
P/B | 22 | ||
P/E | -158 | ||
PEG | 6 | ||
Price/Free Cash Flow | -69 | ||
Price/Operating Cash Flow | -71 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 35 | ||
Last Split Date | 07/25/2016 | ||
Earnings & Revenue